Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people feel very little in the first 24 hours on Mounjaro. The starting dose of 2.5mg is deliberately low — it is there to let your body adjust, not to drive rapid weight loss — so dramatic effects in the opening day are unusual. What you can expect is a modest shift in appetite and, for some, mild nausea that typically passes quickly. Mounjaro (tirzepatide) is a prescription-only medicine, and whether it is clinically suitable for you is a decision your prescriber makes after a full assessment, not something that can be judged from a symptom list alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed more than 2,500 adults taking tirzepatide over 72 weeks, the longest and most detailed dataset we have on how the medicine behaves across time. One consistent finding across the trial was that the 2.5mg dose produced few early side effects, because the first pen's job is physiological adjustment, not treatment at full effect. Participants experienced meaningful weight loss only as doses increased over subsequent months.
That framing matters for the first 24 hours. Some people notice a slight queasiness after their first injection, most noticeable in the hours that follow. Others notice their appetite feels slightly quieter than usual at the next meal. A smaller number feel very little different at all. All three experiences are normal, and none of them tells you much about how well the medicine will ultimately work for you. The clinical evidence is clear that meaningful, sustained results build gradually, not within a day.
The NHS tirzepatide medicine page confirms that nausea is the most commonly reported early side effect, generally described as mild and short-lived. Drinking water slowly, eating smaller portions and avoiding rich or fatty food in the hours after your injection can make the first day more comfortable. You can read more about the broader picture of how Mounjaro works as a treatment if you want background before or after your first dose.
Mounjaro is given as a once-weekly subcutaneous injection using the pre-filled KwikPen. If you are ordering through a registered online pharmacy, your pen arrives in plain, unbranded packaging via tracked DPD delivery, you will get a notification when it is on its way, so there is no anxious guessing. The pen is stored in the fridge between 2°C and 8°C until you are ready to use it; for exact storage details, including the limited window during which it can be kept at room temperature, the Mounjaro Patient Information Leaflet is the definitive guide. You will find it inside the box.
For the injection, you choose a site (the abdomen, thigh or upper arm all work) and rotate locations from week to week to avoid any local irritation building up. A little redness or tenderness at the injection site is common on the first day and rarely lasts beyond 24 hours. If you have not injected before, a guide to giving your first Mounjaro injection covers technique in detail. Concerns about getting it right are among the questions our prescribers hear most often, it is a genuinely normal thing to feel uncertain about, and most people find the process straightforward once they have done it once.
After injecting, keep the used pen in a proper sharps disposal container, not a household bin. Your pharmacy should advise you on disposal; it is a step worth planning before the first dose rather than after.
Mild nausea, a reduced appetite and occasional fatigue are the effects most people report in their first 24 hours. These are consistent with how tirzepatide works, it activates both GIP and GLP-1 receptors involved in appetite regulation and slows how quickly the stomach empties, which is what produces that sensation of fullness (and, in some, early queasiness).
Most first-day side effects are mild and do not need medical attention. What does need urgent attention is severe, persistent abdominal pain, particularly pain that radiates into the back. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis as a known, though infrequent, serious side effect. If that type of pain develops, seek medical help the same day rather than waiting to see if it passes. Signs of an allergic reaction (swelling, difficulty breathing, a widespread rash) also require immediate assessment.
For a broader overview of what to expect across your first week, the first few days on Mounjaro covers what typically changes between day one and day seven. And if you have questions about cost or want to understand what private treatment involves before you start, the Mounjaro pricing guide explains what an all-inclusive private prescription covers.
A quiet first day is not a sign the medicine is not working. Equally, a nauseous first day is not a sign something has gone wrong. The clinical programme for tirzepatide shows that outcomes vary considerably between individuals, weight loss at 15mg ranged widely across SURMOUNT-1 participants, even among those who responded well. Lottie Moss has spoken publicly about her experience with Mounjaro, and her account is a useful reminder that the first injection is far too early to draw conclusions.
What the first 24 hours is useful for is practical learning: how your body responds to the injection site, how your appetite feels at your next meal, whether timing the dose with a lighter evening works better for you. Small adjustments in those early weeks (eating protein first, keeping well hydrated, avoiding alcohol) tend to make the titration phase more comfortable. None of those choices should be made without your prescriber's input; if something feels wrong or you are unsure whether a symptom is normal, contact your prescribing pharmacy or clinical team rather than adjusting the dose yourself.
If you are still deciding whether treatment is right for you, our treatment overview sets out the options clearly. When you are ready to speak to a prescriber, you can start a free consultation with the nume clinical team, your answers are reviewed by a GPhC-registered Independent Prescriber, not automated software, and you will hear back the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.